Eiger BioPharmaceuticals, Inc. 4/A SEC Filings

Filed On	Filing
15 Sep 2016	Form 4/A: Cory David A, Director Granted 285,991 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Kjellson Nina S, Director Granted 25,000 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Engleman Edgar, Director Granted 25,000 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Welch James H, Chief Financial Officer Granted 57,571 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Shaffer James P, Chief Business Officer Granted 60,699 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Quan Joanne, Chief Medical Officer Granted 53,452 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Martins Eduardo Bruno, SVP, Liver and Infectious Dise Granted 65,216 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Glenn Jeffrey S, Director Granted 55,000 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Dietz Thomas John, Director Granted 48,000 Stock Option (Right to Buy)
15 Sep 2016	Form 4/A: Bramlage Charles, Director Granted 25,000 Stock Option (Right to Buy)

Comments